Coherus Oncology, Inc.
CHRS
$1.13
-$0.04-3.42%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 188.36% | -34.59% | 28.97% | -38.65% | -38.70% |
| Total Receivables | 91.62% | -48.96% | -38.46% | -36.60% | 10.35% |
| Inventory | 28.28% | -94.98% | 47.13% | -23.36% | 0.30% |
| Prepaid Expenses | -19.36% | -1.42% | -6.93% | 8.42% | 6.40% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 22.58% | -9.19% | -7.44% | -33.86% | -11.08% |
|
|
|||||
| Total Current Assets | 22.58% | -9.19% | -7.44% | -33.86% | -11.08% |
| Net Property, Plant & Equipment | -15.47% | -69.33% | 152.66% | -12.69% | -20.39% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -1.26% | -1.24% | -1.23% | -2.06% | -2.89% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -10.89% | -87.69% | -41.65% | 35.46% | -22.25% |
| Total Assets | 18.43% | -17.27% | -11.18% | -25.17% | -11.62% |
|
|
|||||
| Total Accounts Payable | -8.08% | 43.84% | 29.98% | -71.50% | 100.63% |
| Total Accrued Expenses | -35.33% | -18.09% | 0.01% | -5.14% | -18.16% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -2.17% | -36.77% | -25.47% | -7.50% | -97.67% |
| Total Finance Division Other Current Liabilities | 294.59% | 6.94% | -42.47% | -69.99% | 363.89% |
| Total Other Current Liabilities | 294.59% | 6.94% | -42.47% | -69.99% | 363.89% |
| Total Current Liabilities | 3.37% | -9.87% | -4.26% | -36.16% | -13.99% |
|
|
|||||
| Total Current Liabilities | 3.37% | -9.87% | -4.26% | -36.16% | -13.99% |
| Long-Term Debt | -87.50% | 0.80% | 0.20% | 0.65% | -3.21% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -15.70% | -13.15% | -12.07% | -10.28% | -11.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 836.49% | 3.06% | 0.00% | 0.00% | -36.58% |
| Total Liabilities | -42.36% | -4.48% | -2.10% | -21.87% | -10.22% |
|
|
|||||
| Common Stock & APIC | 0.39% | 0.36% | 0.47% | 0.49% | 0.76% |
| Retained Earnings | 18.52% | -3.65% | -3.38% | -0.72% | -0.88% |
| Treasury Stock & Other | 0.00% | 0.00% | 0.00% | -1.10% | 0.00% |
| Total Common Equity | 165.31% | -39.00% | -50.03% | -4.60% | -2.77% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 165.31% | -39.00% | -50.03% | -4.60% | -2.77% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 165.31% | -39.00% | -50.03% | -4.60% | -2.77% |
|
|
|||||